HIV Infections Clinical Trials in Chicago, Illinois

5 studies are recruiting for hiv infections in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

   The goal of this observational study is to generate real-life information on the use of lenacapavir (LEN, YEZTUGO®, (YTG)) for pre-exposure prophylaxis (PrEP) across diverse clinical settings in the United States. The study will characterize how PrEP is initiated, used, and discontinued in routine …

   Stage

   Not phased

   Ages

   18 and older

   Site

   DOM/Project WISH Research Clinic, Chicago, Illinois

   Locations

   38 in total

   Run by

   Gilead Sciences

   See if you can join NCT07473778 on ClinicalTrials.gov

2. Dasatinib for HIV-1 Reservoir Reduction

   This study will test if the medicine dasatinib can lower the hidden amount of HIV in the body, called the HIV "reservoir." It will also check if dasatinib is safe and easy to take for people living with HIV who have a suppressed viral load while on antiretroviral therapy (ART). Adults 18 years or o…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Northwestern University CRS (Site # 2701), Chicago, Illinois

   Locations

   3 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT07342491 on ClinicalTrials.gov

3. A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

   This clinical study is testing a new medication, VH4524184, to see if it can effectively treat HIV-1 in adults who have never received treatment for their infection. The study is comparing two different doses of VH4524184, each taken with the medications emtricitabine and tenofovir alafenamide (FTC…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   GSK Investigational Site, Chicago, Illinois

   Locations

   123 in total

   Run by

   ViiV Healthcare

   See if you can join NCT07202546 on ClinicalTrials.gov

4. IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)

   The scientific premise of this research is that individual, interpersonal, and structural factors impact Black girls' sexual reproductive health outcomes (sexually transmitted infection (STI) and Human Immunodeficiency Virus (HIV)) and experience of sexual violence. This study expands STI/HIV preve…

   Stage

   Not phased

   Ages

   13 and older

   Site

   University of Illinois Chicago, Chicago, Illinois

   Run by

   University of Illinois at Chicago

   See if you can join NCT06266416 on ClinicalTrials.gov

5. Keeping it LITE: Exploring HIV Risk in Vulnerable Youth With Limited Interaction and Digital Health Intervention

   Despite advances in HIV diagnostics, care and prevention strategies, infection rates among adolescent and young adult sexual and gender minorities (SGM) continue to rise in the United States (US). There is an urgent need to describe the epidemiology and trajectories of HIV acquisition in this popul…

   Stage

   Not phased

   Ages

   13 to 34

   Site

   John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois

   Run by

   Hektoen Institute for Medical Research

   See if you can join NCT05848570 on ClinicalTrials.gov